2 completed, 1 terminated. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Terminated 1 |
| Phase 2 | 1 | Completed 1 |
Follow BKM120: new trials by email Literature Review of BKM120 trials Research Report on BKM120
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi Fulvestrant, BKM120, BKM120 matching placebo - Metastatic Breast Cancer | Phase 3 | Terminated | Novartis Pharmaceuticals | 432 | 2012-10-03 | 2019-01-30 |
| Phase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metastatic Breast Cancer Refractory to Aromatase Inhibitor Fulvestrant, BKM120, BKM120 matching placebo - Breast Cancer | Phase 3 | Completed | Novartis Pharmaceuticals | 1147 | 2012-08-07 | 2020-08-25 |
| A Study of the Experimental Drug BKM120 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast Cancer, With or Without PI3K Activation Paclitaxel, BKM120 matching placebo, BKM120 - Breast Cancer | Phase 2 / Phase 3 | Completed | Novartis Pharmaceuticals | 416 | 2012-08-01 | 2017-03-09 |
Breast Neoplasms (3) · Neoplasm Metastasis (3) · Hereditary Sensory and Autonomic Neuropathies (2)
Austria (3) · Belgium (3) · Canada (3) · France (3) · Germany (3) · Hungary (3) · Italy (3) · Netherlands (3) · South Korea (3) · Spain (3) · United Kingdom (3) · United States (3) · Argentina (2) · Australia (2) · Brazil (2)